Neurocritical Care Society

Acasti Announces Second Quarter 2024 Financial Results and Business Highlights

Retrieved on: 
Monday, November 13, 2023
Well, NDA, Research, ACST, Food, SAH, ADAR1, Bank statement, Investment, Clinical trial, Depreciation, Patient, Calendar, FDA, Nimodipine, Neurocritical Care Society, Potential New Boyfriend, Massachusetts General Hospital, Doctor of Philosophy, LP, Poster, Cryptocurrency, Pharmaceutical industry, Nursing, Security (finance), MD

The prestigious UTHealth Houston is the first site to enroll an aSAH patient in the STRIVE-ON trial.

Key Points: 
  • The prestigious UTHealth Houston is the first site to enroll an aSAH patient in the STRIVE-ON trial.
  • STRIVE-ON trial on track for potential NDA submission with the FDA anticipated to occur in the first half of calendar 2025.
  • Acasti previously announced alignment with FDA on GTX-104 pivotal Phase 3 trial protocol and obtained guidance on potential NDA submission package.
  • Results of a pharmacokinetic comparison of GTX-104 with oral nimodipine presented as a poster at the 2023 Neurocritical Care Society annual meeting.

The Inner Circle Acknowledges, J. Hudson Garrett, Jr. as a Pinnacle Life Professional for his contributions to the field of Health Care Administration and Policy

Retrieved on: 
Monday, September 11, 2023
Knowledge, American Hospital Association, Society, Infection, Neurocritical Care Society, Hope End, Inner circle, American College of Physicians, Health, Health administration, Journal, Theodore Levitt, Division, Practitioner, Pandemic, Nurse practitioner, Antimicrobial, American College, National Association, Hum Honorary Lifetime Achievement Award, University, Vascular access, Learning, Infectious Diseases Society of America, COVID-19, Georgia State University, Multimedia, Harvard Business Review, University of Louisville School of Medicine, Endemism, Public health, Control, Allied health professions, Society of Critical Care Medicine, Journal of the American Association of Nurse Practitioners, Above, Patient safety, Emergency medical services, Critical Care Medicine (journal), Nursing, Policy, Physician, Medicine

ATLANTA, Sept. 11, 2023 /PRNewswire/ -- Prominently featured in The Inner Circle, J. Hudson Garrett, Jr. is acknowledged as a Pinnacle Life Professional for his contributions to the field of Health Care Administration and Policy.

Key Points: 
  • ATLANTA, Sept. 11, 2023 /PRNewswire/ -- Prominently featured in The Inner Circle, J. Hudson Garrett, Jr. is acknowledged as a Pinnacle Life Professional for his contributions to the field of Health Care Administration and Policy.
  • Dr. Garrett Jr. pursued graduate education at Georgia State University where he earned a Ph.D. in Health Care Administration and Policy after earning a Master's degree in Business, Nursing, and Public Health.
  • With more than 22 years of experience in the field, Dr. Garrett Jr. established Community Health Associates in 2005 to bring healthcare professionals lifesaving emergency care and safety training.
  • The primary service the company offers is consulting to the healthcare industry, including providers, leaders, medical device companies, pharmaceutical companies, and others.

Acasti Announces First Quarter 2024 Financial Results and Business Highlights

Retrieved on: 
Friday, August 11, 2023
SAB, Workforce, Subarachnoid hemorrhage, AUC, Hypotension, Bank statement, ACST, Calendar, NDA, Coronavirus Scientific Advisory Board, Research, Neurocritical Care Society, Doctor of Philosophy, Sale, NCS, Capsule, Hospital, Neurosurgery, MD, Patient, Physician, Pivotal, Depreciation, Poster, FDA, Regulation of food and dietary supplements by the U.S. Food and Drug Administration, Safety, Food, Wuxi, Pharmaceutical industry, Cryptocurrency, Risk management, Nimodipine

With the efficiencies gained through our operational realignment, we reiterate that our projected cash runway now extends to the second quarter of 2025, inclusive of the potential NDA submission.

Key Points: 
  • With the efficiencies gained through our operational realignment, we reiterate that our projected cash runway now extends to the second quarter of 2025, inclusive of the potential NDA submission.
  • Significant extension of the Company's cash runway facilitates the achievement of critical value inflection milestones, including a potential NDA filing for GTX-104.
  • Evaluation of strategic alternatives to maximize value of de-prioritized pipeline assets (GTX-102 and GTX-101) including out-licensing or sale.
  • Key trial design features include:
    Approximately 100 patients will be enrolled at an estimated 25 hospitals in the U.S.

Acasti to Present GTX-104 Pharmacokinetic Comparison Data at Neurocritical Care Annual Meeting

Retrieved on: 
Wednesday, August 9, 2023
ACST, NCS, Subarachnoid hemorrhage, Neurocritical Care Society, Pharmaceutical industry, Nimodipine

PRINCETON, N.J., Aug. 09, 2023 (GLOBE NEWSWIRE) -- Acasti Pharma Inc. (Nasdaq: ACST) ("Acasti" or the "Company"), a late-stage, biopharma company advancing GTX-104 its novel formulation of nimodipine that addresses the high unmet medical needs for a rare disease, aneurysmal subarachnoid hemorrhage (aSAH), today announced that a poster presenting a pharmacokinetic comparison of GTX-104 with oral nimodipine has been accepted for presentation at the 2023 Neurocritical Care Society (NCS) annual meeting, to be held in Phoenix, AZ August 15-18, 2023.

Key Points: 
  • PRINCETON, N.J., Aug. 09, 2023 (GLOBE NEWSWIRE) -- Acasti Pharma Inc. (Nasdaq: ACST) ("Acasti" or the "Company"), a late-stage, biopharma company advancing GTX-104 its novel formulation of nimodipine that addresses the high unmet medical needs for a rare disease, aneurysmal subarachnoid hemorrhage (aSAH), today announced that a poster presenting a pharmacokinetic comparison of GTX-104 with oral nimodipine has been accepted for presentation at the 2023 Neurocritical Care Society (NCS) annual meeting, to be held in Phoenix, AZ August 15-18, 2023.
  • Details of the presentation are as follows:
    GTX-104, Novel IV Formulation of Nimodipine to Treat Subarachnoid Hemorrhage: a Pharmacokinetic Comparison with Oral Nimodipine

The Inner Circle Acknowledges, Scott Glickman, DO, FACOS, as a Most Trusted Healthcare Professional in the Medical Field for his contributions as a specialist at the Center for Neurosurgery Las Vegas

Retrieved on: 
Wednesday, March 29, 2023
Obesity, Osteopathic medicine in the United States, University, Tetraplegia, American Osteopathic Board of Surgery, Patient, Diabetic neuropathy, Philadelphia College of Osteopathic Medicine, North American Spine Society, Spine, Trauma, Medical specialty, Medicine, Stroke, Brain, Multimedia, American Osteopathic Association Bureau of Osteopathic Specialists, Neurocritical Care Society, Sympathetic nervous system, Inner circle, Ethics committee, Chiari malformation, Congress, DO, Suite, American Osteopathic Association, Medical director, Intracranial pressure, Diagnosis, National Association, Mountain View Hospital, American College, Family, Hotel, Veterinary medicine, Nursing, Chiari, Neurosurgery

Dr. Glickman is also board-certified in neurological surgery by the American Osteopathic Board of Surgery and is a Fellow of the American College of Osteopathic Surgeons.

Key Points: 
  • Dr. Glickman is also board-certified in neurological surgery by the American Osteopathic Board of Surgery and is a Fellow of the American College of Osteopathic Surgeons.
  • Dr. Glickman has more than 20 years of experience in the field of Osteopathic Medicine.
  • He is a founding member and managing partner at the Center for Neurosurgery Las Vegas, located at 6850 North Durango Drive, Suite 301, in Las Vegas, NV.
  • The doctor notes that The Center for Neurosurgery Las Vegas focuses on holistic, patient-centered care through osteopathic, allopathic, and integrative medicine.

Dr. Kushal Bhakta Appointed to LactaLogics Clinical Scientific Advisory Board

Retrieved on: 
Tuesday, January 24, 2023
UC, University, NICU, Master of Business Administration, Johns Hopkins University, Medical director, Infant, Neonatology, Pediatrics, Baylor University, PORT, Breast milk, Neonatal intensive care unit, Hospital, Clinical, Milk, Baylor College of Medicine, CSAB, Coronavirus Scientific Advisory Board, Children's Hospital of Orange County, Orange County, Patient, CHOC, Family, Neurocritical Care Society, Business, Texas Children's Hospital, Medical device, Nursing, Medicine

PORT ST. LUCIE, Fla., Jan. 24, 2023 /PRNewswire-PRWeb/ -- Dr. Kushal Bhakta, a leading neonatologist, has been appointed to the Clinical and Scientific Advisory Board (CSAB) of LactaLogics, a company focused on human milk-based nutrition for at-risk infants.

Key Points: 
  • PORT ST. LUCIE, Fla., Jan. 24, 2023 /PRNewswire-PRWeb/ -- Dr. Kushal Bhakta, a leading neonatologist, has been appointed to the Clinical and Scientific Advisory Board (CSAB) of LactaLogics, a company focused on human milk-based nutrition for at-risk infants.
  • A passionate physician educator, he is an Associate Clinical Professor at the UC Irvine School of Medicine.
  • "We are thrilled to welcome Dr. Bhakta to LactaLogics.
  • He received his Executive MBA from University of Southern California Marshall School of Business and is board certified in pediatrics and neonatal-perinatal medicine.

Scott Glickman, DO, FACOS, is recognized by Continental Who's Who

Retrieved on: 
Monday, November 28, 2022
Patient, Trauma, Chiari malformation, Neurocritical Care Society, Mountain View Hospital, North American Spine Society, National Association, American College, University, Multimedia, Medical specialty, American Osteopathic Board of Surgery, Brain, Spine, Peripheral nervous system, Philadelphia College of Osteopathic Medicine, Medicine, American Osteopathic Association, Peripheral neuropathy, Medical director, American Osteopathic Association Bureau of Osteopathic Specialists, DO, Ethics committee, Stroke, Family, Spinal cord injury, Congress, Intracranial pressure, Osteopathic medicine in the United States, Alternative, Suite, Continental, Obesity, Hotel, Veterinary medicine, Neurosurgery, Chiari

Dr. Glickman is a board-certified and multiple fellowship-trained neurosurgeon with over 20 years of experience in his field.

Key Points: 
  • Dr. Glickman is a board-certified and multiple fellowship-trained neurosurgeon with over 20 years of experience in his field.
  • He is a founding member and managing partner at the Center for Neurosurgery Las Vegas, located at 6850 North Durango Drive, Suite 301, in Las Vegas, NV.
  • He also has in-depth experience with deep brain stimulator therapy as well as open and minimally invasive spinal surgery techniques.
  • According to Dr. Glickman, the Center for Neurosurgery Las Vegas focuses on holistic, patient-centered care through osteopathic, allopathic, and integrative medicine.

Xoran Success With TRON™ at Fall Neuro and Spine Meetings

Retrieved on: 
Monday, October 24, 2022
TRON, ANN, Congress, CBCT, Critical care, Patient, Minimally invasive spine surgery, NASS, Partnership, NCS, Technology, Radiological Society of North America, CT, Spine, Congress of Neurological Surgeons, Industry, Society, RSNA, CNS, Robotics, FDA, North American Spine Society, Neurocritical Care Society, Surgeon, Medical imaging

"... envision how our [CT] systems will revolutionize patient access to safer, more successful procedures."

Key Points: 
  • "... envision how our [CT] systems will revolutionize patient access to safer, more successful procedures."
  • "It was great to witness the overwhelmingly positive response from the neuroscience clinical community at recent industry meetings," says Xoran Senior Commercialization Advisor Rob Korn.
  • "With the recently FDA-cleared TRON, Xoran is leveraging twenty-plus years of technology innovation and design to further increase our focus on the neuroscience and spine markets.
  • The customer feedback on both the xCAT IQ and TRON for intraoperative and critical care use at these recent, high-profile meetings has been extremely exciting and encouraging."

IRRAS Announces Participation and Educational Symposium at Key Upcoming Neurosurgery Conferences

Retrieved on: 
Wednesday, October 5, 2022
Subarachnoid hemorrhage, CA, Congress, CET, Jean-Louis Vincent, Review, CSF, SAH, Patient, Hospital, Neurocritical Care Society, NCS, Congress of Neurological Surgeons, Health, Awareness, CNS, Lifespan, Nasdaq Stockholm, Neurosurgery, Brain, Poster, Pharmaceutical industry, Medical device, Nightclub

IRRAS will participate in the "Neurotrauma Across the Lifespan and Around the World" symposium at CNS on Sunday, October 9, 2022, beginning at 0800 PDT, which will provide hands-on product training to symposium attendees.

Key Points: 
  • IRRAS will participate in the "Neurotrauma Across the Lifespan and Around the World" symposium at CNS on Sunday, October 9, 2022, beginning at 0800 PDT, which will provide hands-on product training to symposium attendees.
  • Attendees at both conferences are encouraged to visit the IRRAS booths to learn more.
  • In addition to the neurotrauma symposium participation at CNS, clinical data regarding the use of the IRRAflowsystem will also be presented.
  • IRRAS is a global medical care company focused on delivering innovative medical solutions to improve the lives of critically ill patients.

IRRAS Announces Participation and Educational Symposium at Key Upcoming Neurosurgery Conferences

Retrieved on: 
Wednesday, October 5, 2022
Subarachnoid hemorrhage, CA, Congress, CET, Jean-Louis Vincent, Review, CSF, SAH, Patient, Hospital, Neurocritical Care Society, NCS, Congress of Neurological Surgeons, Health, Awareness, CNS, Lifespan, Nasdaq Stockholm, Neurosurgery, Brain, Poster, Pharmaceutical industry, Medical device, Nightclub

IRRAS will participate in the "Neurotrauma Across the Lifespan and Around the World" symposium at CNS on Sunday, October 9, 2022, beginning at 0800 PDT, which will provide hands-on product training to symposium attendees.

Key Points: 
  • IRRAS will participate in the "Neurotrauma Across the Lifespan and Around the World" symposium at CNS on Sunday, October 9, 2022, beginning at 0800 PDT, which will provide hands-on product training to symposium attendees.
  • Attendees at both conferences are encouraged to visit the IRRAS booths to learn more.
  • In addition to the neurotrauma symposium participation at CNS, clinical data regarding the use of the IRRAflowsystem will also be presented.
  • IRRAS is a global medical care company focused on delivering innovative medical solutions to improve the lives of critically ill patients.